Okyo Pharma Limited ADR (OKYO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2022 | 03-2022 | 03-2021 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 746 | 2,701 | 6,889 |
| Receivables | 1,119 | 1,595 | 97 |
| Other current assets | 1 | -1 | 1 |
| TOTAL | $1,866 | $4,295 | $6,987 |
| Non-Current Assets | |||
| PPE Net | N/A | 10 | 8 |
| TOTAL | $N/A | $10 | $8 |
| Total Assets | $1,871 | $4,301 | $7,091 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 2,104 | 1,306 | 1,673 |
| Other current liabilities | 132 | 47 | 0 |
| TOTAL | $2,236 | $1,353 | $1,707 |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $65 |
| Total Liabilities | $2,236 | $1,353 | $1,772 |
| Shareholders' Equity | |||
| Retained earnings | -95,878 | -112,426 | -106,004 |
| Other shareholders' equity | 2,859 | -8,604 | -306 |
| TOTAL | $-365 | $2,947 | $5,319 |
| Total Liabilities And Equity | $1,871 | $4,300 | $7,091 |